This event is designed to bring together clinical and pathway professionals to explore evolving practices in the management of Acute Myeloid Leukaemia (AML). It will serve as a platform to:
- Review recent changes in AML diagnostics, including molecular profiling, risk stratification, and early detection strategies.
- Discuss updates to treatment pathways, with a focus on personalised medicine, novel therapies, and multidisciplinary coordination.
- Facilitate implementation of NICE guidance across the AML pathway, ensuring alignment with national standards and improving patient outcomes.
- Encourage cross-team collaboration, enabling shared learning and consistent practice across Greater Manchester.
The event will also provide opportunities for attendees to:
- Engage with experts and peers on challenges and innovations in AML care.
- Contribute to shaping future pathway developments.
- Receive updates from the GM Cancer Alliance’s Workforce & Education Programme